Dr. Paolo Romanelli, MD

Dr. Romanelli practices at UMiami Medicine - Dermatology in Miami, Florida.

Dr. Romanelli's NPI, 1013945724, was assigned on June 29, 2006. Dr. Romanelli graduated from University of Pisa Faculty of Medicine in 1984. Dr. Romanelli holds Florida license ME100776.

Dr. Romanelli's primary practice is UMiami Medicine - Dermatology, at 1444 NW 9th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Dr. Romanelli's primary practice is UMiami Medicine - Dermatology in Miami, Florida. Dr. Romanelli is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Romanelli practices. Vendor and product names are available with a free account.

Dermatology is Dr. Romanelli's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Romanelli is board certified in dermatology by the American Board of Dermatology. Dr. Romanelli is licensed in Florida.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, rash, scalp rash and skin cyst among the conditions Dr. Romanelli treats.

CMS data shows 466 Medicare services from Dr. Romanelli across 9 procedure codes in 2024, for 136 Medicare patients. Medicare paid $25,904 for them. Every service was in an office.

CMS counts 136 Medicare patients who saw Dr. Romanelli in 2024. The largest group is 75 to 84, with 64 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Romanelli's median patient age at 62, with 47% women.

In 2024, Dr. Romanelli wrote 637 Medicare Part D claims for 105 patients. 59% of them were for generic drugs. CMS names the drug for 467 of them, across 20 drugs with 11 or more claims each, at $1,432,723 in total drug cost. In 2023, CMS named 523 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Romanelli for performance year 2024, reported as part of a group. Dr. Romanelli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 83 procedures of removal of skin lesions by Dr. Romanelli, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Romanelli, published from 2022 to 2024. 2023 was the busiest year, with 3. Dr. Romanelli's most frequent co-authors are Mehrdad Nadji, Victoria Lauren Billero and Alain Brassard, MD.

CMS Open Payments shows 308 general payments to Dr. Romanelli from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Boehringer Ingelheim USA, Inc. paid the most, $9,823.

Dr. Romanelli graduated from University of Pisa Faculty of Medicine in 1984.

Dr. Romanelli is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.